Suicidality clinical trials at UCLA
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This is a pilot study to analyze the benefit of accelerated continuous Transcranial magnetic stimulation for inpatient subjects suffering with suicidal ideation. This study will enroll 40 inpatient subjects recruited from the Resnick Neuropsychiatric hospital. Subjects will be blinded and randomized to active or sham TMS treatment and will receive up to 5 assigned treatments per day. Subjects will also be asked to complete mood surveys throughout their participation. Participation in this study will last 7-10 days depending on scheduling.
Los Angeles, California
Our lead scientists for Suicidality research studies include Andrew F. Leuchter.